Cresco Labs (STU:6CQ) Cyclically Adjusted PB Ratio: (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:6CQ Cresco Labs Inc STU:6CQ
40 GF Score
Price €0.67
GF Value €0.76
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cresco Labs Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cresco Labs  (STU:6CQ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cresco Labs Cyclically Adjusted PB Ratio Related Terms


Cresco Labs Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Cresco Labs's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Cyclically Adjusted PB Ratio Chart

Cresco Labs Annual Data
Trend Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cresco Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:6CQ vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted PB Ratio falls into.


STU:6CQ
40GF Score
Cresco Labs Inc STU:6CQ
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cresco Labs Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cresco Labs's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Cresco Labs's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.84/333.9520*333.9520
=0.840

Current CPI (Jun. 2026) = 333.9520.

Cresco Labs Quarterly Data

Book Value per Share CPI Adj_Book
201607 -21.943 240.628 -30.453
201610 -21.629 241.729 -29.881
201701 -24.743 242.839 -34.027
201704 -23.943 244.524 -32.700
201707 -24.771 244.786 -33.794
201710 -23.914 246.663 -32.377
201801 -24.914 247.867 -33.567
201804 -24.286 250.546 -32.371
201807 -22.343 252.006 -29.608
201810 -0.212 252.885 -0.280
201903 0.953 254.202 1.252
201906 0.911 256.143 1.188
201909 1.207 256.759 1.570
201912 1.280 256.974 1.663
202003 2.745 258.115 3.552
202006 2.550 257.797 3.303
202009 2.397 260.280 3.075
202012 1.741 260.474 2.232
202103 2.117 264.877 2.669
202106 2.738 271.696 3.365
202109 2.080 274.310 2.532
202112 2.300 278.802 2.755
202203 2.251 287.504 2.615
202206 2.530 296.311 2.851
202209 2.648 296.808 2.979
202212 1.965 296.797 2.211
202303 1.879 301.836 2.079
202306 1.711 305.109 1.873
202309 1.405 307.789 1.524
202312 1.365 306.746 1.486
202403 1.353 312.332 1.447
202406 1.250 314.175 1.329
202409 1.184 315.301 1.254
202412 1.301 315.605 1.377
202503 1.212 319.799 1.266
202506 1.084 322.561 1.122
202509 1.021 324.800 1.050
202512 0.809 324.054 0.834
202603 0.785 330.213 0.794
202606 0.840 333.952 0.840

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cresco Labs (STU:6CQ) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of €0.67 is trading 11.4% below its estimated GF Value™ of €0.76. GuruFocus considers Cresco Labs to be Modestly Undervalued.

Key valuation signals for STU:6CQ:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €0.76 vs. price of €0.67 (11.4% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the STU:6CQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cresco Labs Business Description

Other Exchanges CRLBF:USACL:Canada
Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
40GF Score

Get the complete analysis for STU:6CQ

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.67
Price
€0.76
GF Value